Funder: National Institutes of Health

Due Dates: May 7, 2025 (AIDS-related) | June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS-related) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS-related) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS-related)

Funding Amounts: Direct costs up to $275,000 over two years (max $200,000 in any single year); project period up to 2 years.

Summary: Supports exploratory and innovative neuroscience research at early, conceptual stages in NINDS and NIMH scientific mission areas; clinical trials are not allowed.

Key Information: Only mechanistic or basic experimental studies with humans (BESH) are permitted; standard NIH R21 requirements apply.